| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJMCIBR0806723 |
| P698 | PubMed publication ID | 18946072 |
| P2093 | author name string | Laurie J Goodyear | |
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1842-1844 | |
| P577 | publication date | 2008-10-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | The exercise pill--too good to be true? | |
| P478 | volume | 359 |
| Q34299825 | A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD. |
| Q35237607 | A study of the effects of exercise on the urinary metabolome using normalisation to individual metabolic output |
| Q37872742 | AMP-activated protein kinase modulators: a patent review (2006 - 2010). |
| Q24610297 | AMP-activated protein kinase, stress responses and cardiovascular diseases |
| Q38026549 | AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases |
| Q37531997 | Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations. |
| Q53811463 | Aerobic training as an adjunctive therapy to enzyme replacement in Pompe disease. |
| Q90146179 | Anti-inflammatory Property of AMP-activated Protein Kinase |
| Q28476727 | Arctigenin efficiently enhanced sedentary mice treadmill endurance |
| Q42914451 | Catalase activity prevents exercise-induced up-regulation of vasoprotective proteins in venous tissue |
| Q33894407 | Cellular bioenergetics as a target for obesity therapy |
| Q47688453 | Chronic β2 -adrenoceptor agonist treatment alters muscle proteome and functional adaptations induced by high intensity training in young men. |
| Q55415253 | Concurrent treatment with ursolic acid and low-intensity treadmill exercise improves muscle atrophy and related outcomes in rats. |
| Q35089784 | Current and future drug targets in weight management |
| Q36854677 | Dealing with ambiguity: Israeli physician's attitudes and practices regarding pre-exercise certificates: a questionnaire study. |
| Q34299677 | Detection of PPARδ agonists GW1516 and GW0742 and their metabolites in human urine. |
| Q46194234 | Effect of increased physical activity on fructose-induced glycemic response in healthy individuals |
| Q47992683 | Emerging drugs: mechanism of action, mass spectrometry and doping control analysis |
| Q36252826 | Exercise acts as a drug; the pharmacological benefits of exercise |
| Q36933850 | Exercise-like effects by Estrogen-related receptor-gamma in muscle do not prevent insulin resistance in db/db mice. |
| Q38119906 | From gene engineering to gene modulation and manipulation: can we prevent or detect gene doping in sports? |
| Q34551710 | Impaired musculoskeletal response to age and exercise in PPARβ(-/-) diabetic mice |
| Q37590547 | Lack of adequate appreciation of physical exercise's complexities can pre-empt appropriate design and interpretation in scientific discovery |
| Q34031701 | Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training |
| Q92485483 | Mitochondrial disorders and drugs: what every physician should know |
| Q35532249 | Muscle-Specific Overexpression of PGC-1α Does Not Augment Metabolic Improvements in Response to Exercise and Caloric Restriction |
| Q36619416 | Neuronal nitric oxide synthase is indispensable for the cardiac adaptive effects of exercise. |
| Q37528136 | Novel pharmacological approaches to combat obesity and insulin resistance: targeting skeletal muscle with 'exercise mimetics'. |
| Q46972562 | Obesity Drug Update: The Lost Decade? |
| Q35973671 | Of mice and men: the benefits of caloric restriction, exercise, and mimetics. |
| Q30396041 | One-day workshop-based training improves physical activity prescription knowledge in Latin American physicians: a pre-test post-test study |
| Q34121822 | Optimal management of sarcopenia |
| Q44994548 | PPARgamma agonist pioglitazone does not enhance performance in mice. |
| Q24634396 | Peroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophy |
| Q34236724 | Peroxisome proliferator-activated receptor {gamma} coactivator 1{alpha} (PGC-1{alpha}) promotes skeletal muscle lipid refueling in vivo by activating de novo lipogenesis and the pentose phosphate pathway. |
| Q37031057 | Resistance to aerobic exercise training causes metabolic dysfunction and reveals novel exercise-regulated signaling networks. |
| Q57537597 | Sedentarismo, exercício físico e doenças crônicas |
| Q64082528 | Targeting RalGAPα1 in skeletal muscle to simultaneously improve postprandial glucose and lipid control |
| Q38836199 | Targeting vascular (endothelial) dysfunction. |
| Q36038197 | The AMPK activator R419 improves exercise capacity and skeletal muscle insulin sensitivity in obese mice. |
| Q60920897 | The Role of Exercise in the Quality of Life in Patients After Pancreatectomy: A Prospective Randomized Controlled Trial |
| Q36209248 | Utilizing small nutrient compounds as enhancers of exercise-induced mitochondrial biogenesis |
| Q39350536 | Voluntary Running Attenuates Metabolic Dysfunction in Ovariectomized Low-Fit Rats |
Search more.